Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “estradiol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 26
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 26 pipeline programs matching "estradiol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

26 results for “estradiol” Back to intelligence hub

Search results

Page 1 of 2
  1. 91781

    Bayer HealthCare AG

    Primary Dysmenorrhea

    phase 3 small molecule completed

    1 trial
  2. Estradiol

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    2 trials
  3. Estradiol

    Teva Pharma GmbH

    Dyspareunia

    phase 3 small molecule completed

    1 trial
  4. Estradiol

    TherapeuticsMD

    Vulvovaginal Atrophy

    phase 3 small molecule completed

    1 trial
  5. Estradiol Vaginal Tablets 10 mcg

    Amneal Pharma Europe Ltd

    Atrophic Vaginitis Due to Menopause

    phase 3 small molecule completed

    1 trial
  6. Generic Estradiol Vaginal Cream USP, 0.01%

    Teva Pharma GmbH

    Atrophic Vaginitis

    phase 3 small molecule completed

    1 trial
  7. Levonorgestrel 100 mcg and Ethinyl Estradiol 20 mcg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Contraceptive

    phase 3 small molecule active

    1 trial
  8. Seasonale (levonorgestrel and ethinyl estradiol)

    Teva Pharma GmbH

    Osteopenia

    phase 3 small molecule terminated

    1 trial
  9. Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]

    Teva Pharma GmbH

    Healthy

    phase 3 small molecule completed

    1 trial
  10. oral estradiol 1.0 mg

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    1 trial
  11. 2-methoxyestradiol

    CASI Pharmaceuticals

    Relapsed Multiple Myeloma

    phase 2 small molecule completed

    1 trial
  12. 9941

    CNS Pharmaceuticals

    Menopause

    phase 2 small molecule terminated

    1 trial
  13. Cyproterone acetate/ethinylestradiol (CPA/EE)

    Universal Integrated

    Polycystic Ovarian Syndrome

    phase 2 small molecule completed

    1 trial
  14. ME-CLN-002

    CASI Pharmaceuticals

    Carcinoid Tumor

    phase 2 small molecule completed

    1 trial
  15. Population Council #323

    United Therapeutics Europe Ltd

    Contraception

    phase 2 small molecule completed

    1 trial
  16. desogestrel/ethinyl estradiol and ethinyl estradiol

    Teva Pharma GmbH

    Hemostasis

    phase 2 small molecule completed

    1 trial
  17. Desogestrel/ethinyl estradiol and ethinyl estradiol

    Teva Pharma GmbH

    Follicle Development

    phase 1 small molecule completed

    1 trial
  18. Drospirenone/Ethinyl Estradiol (Gianvi®)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  19. Estradiol/Norethindrone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  20. Ethinyl Estradioll/Levonorgestrel (EE/LNG)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial
  21. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Bioequivalence

    phase 1 small molecule completed

    1 trial
  22. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  23. Segesterone Acetate and Ethinyl Estradiol

    TherapeuticsMD

    Contraception

    phase 1 small molecule completed

    1 trial
  24. Segesterone Acetate and Ethinyl Estradiol

    TherapeuticsMD

    Women

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.